The reiteration of a Buy rating and a $15 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could positively influence Acumen Pharmaceuticals' stock price in the short term. Analyst ratings, especially from well-regarded firms, often have a significant impact on how stocks are perceived in the market, potentially leading to price movements.